Search results

ANSTO's Sydney locations are home to the Open Pool Australian Light-water (OPAL) multi-purpose reactor, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering, the National Research Cyclotron and the National Deuteration Facility.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

ANSTO has collaborated on a study assessing the impact of the commonly-used food additive titanium dioxide (TiO2) on gut microbiota and inflammation.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

Think Science! 2023 Summary and Results

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.

Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Datasets from the Aerosol Sampling Program.

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.